Literature DB >> 24662815

The kinetics of ER fusion protein activation in vivo.

C H Wilson1, I Gamper1, A Perfetto1, J Auw1, T D Littlewood1, G I Evan1.   

Abstract

Reversibly switchable proteins are powerful tools with which to explore protein function in vitro and in vivo. For example, the activity of many proteins fused to the hormone-binding domain of the modified oestrogen receptor (ER(TAM)) can be regulated by provision or removal of 4-hydroxytamoxifen (4-OHT). Despite the widespread use of ER(TAM) fusions in vivo, inadequate data are available as to the most efficacious routes for systemic tamoxifen delivery. In this study, we have used two well-characterized ER(TAM) fusion proteins, both reversibly activated by 4-OHT, to compare the effectiveness and kinetics of 4-OHT delivery in mice in vivo by either tamoxifen in food or by intraperitoneal injection. Our data indicate that dietary tamoxifen offers an effective, facile and ethically preferable means for long-term activation of ER(TAM) fusion proteins in vivo.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24662815      PMCID: PMC4076531          DOI: 10.1038/onc.2014.78

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient.

Authors:  S P Robinson; S M Langan-Fahey; D A Johnson; V C Jordan
Journal:  Drug Metab Dispos       Date:  1991 Jan-Feb       Impact factor: 3.922

2.  Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion.

Authors:  S Pelengaris; T Littlewood; M Khan; G Elia; G Evan
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

3.  Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression.

Authors:  Stella Pelengaris; Michael Khan; Gerard I Evan
Journal:  Cell       Date:  2002-05-03       Impact factor: 41.582

4.  Tamoxifen dose response and conditional cell marking: is there control?

Authors:  Debra Ellisor; Mark Zervas
Journal:  Mol Cell Neurosci       Date:  2010-06-17       Impact factor: 4.314

5.  Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse.

Authors:  Shigemi Hayashi; Andrew P McMahon
Journal:  Dev Biol       Date:  2002-04-15       Impact factor: 3.582

6.  Ligand-activated site-specific recombination in mice.

Authors:  R Feil; J Brocard; B Mascrez; M LeMeur; D Metzger; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.

Authors:  Dorothe Hameyer; Ate Loonstra; Leonid Eshkind; Steffen Schmitt; Cecilia Antunes; Annemiek Groen; Eric Bindels; Jos Jonkers; Paul Krimpenfort; Ralph Meuwissen; Loes Rijswijk; Axel Bex; Anton Berns; Ernesto Bockamp
Journal:  Physiol Genomics       Date:  2007-04-24       Impact factor: 3.107

8.  Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

Authors:  Zeruesenay Desta; Bryan A Ward; Nadia V Soukhova; David A Flockhart
Journal:  J Pharmacol Exp Ther       Date:  2004-05-24       Impact factor: 4.030

9.  Inducible site-directed recombination in mouse embryonic stem cells.

Authors:  Y Zhang; C Riesterer; A M Ayrall; F Sablitzky; T D Littlewood; M Reth
Journal:  Nucleic Acids Res       Date:  1996-02-15       Impact factor: 16.971

10.  A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins.

Authors:  T D Littlewood; D C Hancock; P S Danielian; M G Parker; G I Evan
Journal:  Nucleic Acids Res       Date:  1995-05-25       Impact factor: 16.971

View more
  14 in total

1.  Treg-Cell Control of a CXCL5-IL-17 Inflammatory Axis Promotes Hair-Follicle-Stem-Cell Differentiation During Skin-Barrier Repair.

Authors:  Anubhav N Mathur; Bahar Zirak; Ian C Boothby; Madge Tan; Jarish N Cohen; Thea M Mauro; Pooja Mehta; Margaret M Lowe; Abul K Abbas; Niwa Ali; Michael D Rosenblum
Journal:  Immunity       Date:  2019-03-19       Impact factor: 31.745

2.  Murine supraspinatus tendon injury model to identify the cellular origins of rotator cuff healing.

Authors:  Ryu Yoshida; Farhang Alaee; Felix Dyrna; Mark S Kronenberg; Peter Maye; Ivo Kalajzic; David W Rowe; Augustus D Mazzocca; Nathaniel A Dyment
Journal:  Connect Tissue Res       Date:  2016-05-16       Impact factor: 3.417

3.  Identification of a T-bethi Quiescent Exhausted CD8 T Cell Subpopulation That Can Differentiate into TIM3+CX3CR1+ Effectors and Memory-like Cells.

Authors:  Saravanan Raju; Yu Xia; Bence Daniel; Kathryn E Yost; Elliot Bradshaw; Elena Tonc; Daniel J Verbaro; Kohei Kometani; Wayne M Yokoyama; Tomohiro Kurosaki; Ansuman T Satpathy; Takeshi Egawa
Journal:  J Immunol       Date:  2021-06-04       Impact factor: 5.426

4.  Reversible modulation of SIRT1 activity in a mouse strain.

Authors:  Katherine V Clark-Knowles; Xiaohong He; Karen Jardine; Josée Coulombe; Danielle Dewar-Darch; Annabelle Z Caron; Douglas A Gray; Michael W McBurney
Journal:  PLoS One       Date:  2017-03-08       Impact factor: 3.240

5.  Myc linked to dysregulation of cholesterol transport and storage in nonsmall cell lung cancer.

Authors:  Zoe Hall; Catherine H Wilson; Deborah L Burkhart; Tom Ashmore; Gerard I Evan; Julian L Griffin
Journal:  J Lipid Res       Date:  2020-08-04       Impact factor: 5.922

Review 6.  Advanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the Brain.

Authors:  Brandon J Walters; Amber B Azam; Colleen J Gillon; Sheena A Josselyn; Iva B Zovkic
Journal:  Front Genet       Date:  2016-01-12       Impact factor: 4.599

7.  Myc Cooperates with Ras by Programming Inflammation and Immune Suppression.

Authors:  Roderik M Kortlever; Nicole M Sodir; Catherine H Wilson; Deborah L Burkhart; Luca Pellegrinet; Lamorna Brown Swigart; Trevor D Littlewood; Gerard I Evan
Journal:  Cell       Date:  2017-11-30       Impact factor: 41.582

8.  Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.

Authors:  Sara Di Siena; Federica Campolo; Roberto Gimmelli; Chiara Di Pietro; Daniela Marazziti; Susanna Dolci; Andrea Lenzi; Andre Nussenzweig; Manuela Pellegrini
Journal:  Cell Death Dis       Date:  2018-02-22       Impact factor: 8.469

9.  Gremlin 1 depletion in vivo causes severe enteropathy and bone marrow failure.

Authors:  Simon C Rowan; Hanne Jahns; Liberty Mthunzi; Lucie Piouceau; Joanna Cornwell; Róisín Doody; Stephen Frohlich; John J Callanan; Paul McLoughlin
Journal:  J Pathol       Date:  2020-05-28       Impact factor: 7.996

10.  Erythro-myeloid progenitors contribute endothelial cells to blood vessels.

Authors:  Alice Plein; Alessandro Fantin; Laura Denti; Jeffrey W Pollard; Christiana Ruhrberg
Journal:  Nature       Date:  2018-09-26       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.